Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Urinary podocalyxin and cyclophilin A: markers for early detection of type 2 diabetic nephropathy

El-Saeed Gehan K, Shehab El-Deen Walid A, Montasr Belal A, Omar Thoria A, Mohamed Doaa S

Year : 2019| Volume: 32| Issue : 3 | Page no: 996-1003

   This article has been cited by
 
1 Diabetic kidney disease in pediatric patients: A current review
Carmen Muntean, Iuliana Magdalena Starcea, Claudia Banescu
World Journal of Diabetes. 2022; 13(8): 587
[Pubmed]  [Google Scholar] [DOI]
2 Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes
Nanees Abdel-Badie Salem,Rania Mostafa El Helaly,Ibrahim Maroof Ali,Hala Abd Alem Ebrahim,Mostafa Mahmoud Alayooti,Huda Ahmed El Domiaty,Hadil Mohamed Aboelenin
Pediatric Diabetes. 2020;
[Pubmed]  [Google Scholar] [DOI]
3

Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model

Abdallah Mahmoud El-Ebidi,Tahia H Saleem,Mohamed Gamal El-din Saadi,Hala Abdallah Mahmoud,Zeinab Mohamed,Hoda S Sherkawy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 3807
[Pubmed]  [Google Scholar] [DOI]
4 Role of urinary podocalyxin in early diagnosis of diabetic nephropathy
Irena Kostovska,Katerina Tosheska Trajkovska,Svetlana Cekovska,Sonja Topuzovska,Julijana Brezovska Kavrakova,Goce Spasovski,Ognen Kostovski,Danica Labudovic
Romanian Journal of Internal Medicine. 2020; 58(4): 233
[Pubmed]  [Google Scholar] [DOI]

 

Read this article